Navigation Links
Metabolic syndrome increases risk of both major types of primary liver cancer
Date:7/21/2011

Incidence rates of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) have increased in the U.S. This population-based study publishing in the August issue of Hepatology, a journal of the American Association for the Study of Liver Diseases, found that metabolic syndrome significantly increases risk of developing these primary liver cancers.

According to data from the National Cancer Institute, 24,120 new cases of liver and intrahepatic bile duct cancer and close to 19,000 deaths from the diseases occurred in the U.S. in 2010. Major risk factors for HCC, the most common type of liver cancer, are chronic infection with hepatitis B and C viruses and excessive alcohol consumption. ICC, the second most common type of liver cancer, is associated with primary sclerosing cholangitis and inflammatory bowel disease. However, the cause of up to half of HCC and ICC remains unknown.

"There has been an increase in the incidence rates of liver cancerHCC and ICCin the U.S.," explains lead author Tania Welzel, M.D., with the National Cancer Institute and Klinikum der J.W. Goethe-Universitt. "While metabolic syndrome is a recognized risk factor for HCC and may also modify ICC risk, the magnitude of this effect has not been investigated on a large scale in the U.S." Metabolic syndrome comprises a group of medical conditions which include central obesity (excess abdominal-area weight), raised fasting glucose levels and diabetes mellitus, raised triglycerides, reduced HDL cholesterol, and hypertension.

For the present study, Dr. Welzel and colleagues examined the association between metabolic syndrome and development of primary liver cancers in the general U.S. population. Using the SEER-Medicare database, researchers identified individuals diagnosed with HCC or ICC between 1993 and 2005. A 5% sample of individuals residing in geographic regions similar to SEER registries was selected for comparison purposes. A total of 3649 HCC cases, 743 ICC cases, and 195953 individuals without cancer were identified and met study inclusion criteria.

The findings revealed that metabolic syndrome was present in 37% of persons who subsequently developed HCC and 30% of persons who developed ICC, compared to 17% of persons who didn't develop either cancer. Analyses showed metabolic syndrome was significantly associated with increased risk of HCC (odds ratio=2.13) and ICC (odds ratio=1.56). Individual components of metabolic syndromeimpaired fasting glucose level, dyslipoproteinemia, obesity and hypertensionwere more common among persons who developed either HCC or ICC patients than among persons who did not.

"Our findings show a 2-fold increased risk for HCC and a 1.56-fold increased risk for ICC in those individuals with pre-existing metabolic syndrome," concluded Dr. Welzel. "The risk of developing these primary liver cancers is significant for individuals with this condition. Due to the high prevalence of metabolic syndrome, even small increases in the absolute risk for HCC and ICC may contribute to the increasing liver cancer burden." The authors suggest that metabolic syndrome may be the source behind a number of the idiopathic HCC or ICC cases in the U.S. and efforts to control the worldwide epidemics of obesity and diabetes could reduce the liver cancer burden.


'/>"/>

Contact: Dawn Peters
healthnews@wiley.com
781-388-8408
Wiley-Blackwell
Source:Eurekalert

Related biology news :

1. Key metabolic pathway implicated in intractable form of breast cancer
2. Hold your breath: Air pollution plays role in cardiac, metabolic diseases
3. Study shows pine bark naturally improves kidney function in patients with metabolic syndrome
4. Metabolic cost of human sleep deprivation quantified by University of Colorado team
5. Birch bark ingredient comes with many metabolic benefits
6. Seaweed as biofuel? Metabolic engineering makes it a viable option
7. Longevity breakthrough: The metabolic state of mitochondria controls life span
8. Study finds low vitamin-d levels in northern California residents with metabolic syndrome
9. AgriLife scientist: Functional amino acids regulate key metabolic pathways
10. Imaging reveals key metabolic factors of cannibalistic bacteria
11. Native-like spider silk produced in metabolically engineered bacterium
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2017)... 8, 2017 About Voice Recognition Biometrics Voice ... it against a stored voiceprint template. Acoustic features ... and tone are compared to distinguish between individual ... as most PCs already have a microphone and ... recognition biometrics are most likely to be deployed ...
(Date:2/7/2017)... 2017   MedNet Solutions , an innovative SaaS-based ... clinical research, is pleased to announce that the latest ... highly flexible and award winning eClinical solution, is now ... is a proven Software-as-a-Service (SaaS) clinical research technology ... but also delivers an entire suite of eClinical tools ...
(Date:2/3/2017)... 3, 2017 A new independent identity strategy ... LLP (IdSP) . Designed to fill a critical niche ... market, founding partners Mark Crego and ... just in identity expertise that span federal governments, the ... The Crego-Kephart combined expertise has a common theme born ...
Breaking Biology News(10 mins):
(Date:2/20/2017)... ... February 20, 2017 , ... Researchers ... collapses in pre-term infants with respiratory distress, and assist surgeons with pre-operative ... funding through the ninth round of the University City Science Center’s QED ...
(Date:2/20/2017)... Feb. 20, 2017  Atrius Health and IBM (NYSE: ... an agreement to develop a cloud based service ... a holistic view of the multiple influences on ... Insights could be designed to support shared decision ... an innovative nonprofit healthcare organization with 875 physicians ...
(Date:2/18/2017)... ... February 17, 2017 , ... A ... in Hong Kong. , Nerium International is proud to introduce its Age-Defying Night ... Cream, NeriumAD™ Formula to consumers across Hong Kong. The luxury skincare products contain ...
(Date:2/17/2017)... 2017  If only one in every hundred ... resistance to chemotherapy, thousands of cancer cells would ... on finding these mutations in ever-smaller subpopulations of ... DNA in blood — to guide treatment decisions ... Unfortunately, however, detecting these genetic anomalies may be ...
Breaking Biology Technology: